Andrew J. Perlman

Insider Reports History

Entity
Individual
Location
618 Mirada Ave, Stanford, CA
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Perlman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 29.3K $515K $17.55 Jun 6, 2024 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 24K Jun 6, 2024 Direct

Insider Reports Filed by Andrew J. Perlman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCUS Arcus Biosciences, Inc. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
RCUS Arcus Biosciences, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
RCUS Arcus Biosciences, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
RCUS Arcus Biosciences, Inc. Jun 3, 2021 2 $0 4 Jun 7, 2021 Director